Evidence map›Paper›PMID 30995469›Full record

ArticleCell reports2019

Keap1-Nrf2 System Plays an Important Role in Invariant Natural Killer T Cell Development and Homeostasis.

Kalyani Pyaram, Ajay Kumar, Yeung-Hyen Kim, Sanjeev Noel, Sekhar P Reddy, Hamid Rabb, Cheong-Hee Chang

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  9. Article
  10. Article
  11. The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?Antioxidants (Basel, Switzerland) · 2024
    Review
  12. Invariant natural killer T cells in lung diseases.Experimental & molecular medicine · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. METTL14-dependent mCell reports · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kalyani PyaramDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: kpyaram@umich.edu.
Ajay KumarDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Yeung-Hyen KimDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Sanjeev NoelDivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Sekhar P ReddyDepartment of Pediatrics, College of Medicine, University of Illinois, Chicago, IL, USA.
Hamid RabbDivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Cheong-Hee ChangDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: heechang@umich.edu.
University of Michigan–Ann Arbor · USJohns Hopkins University · USUniversity of Illinois Urbana-Champaign · US

Funding

Innate T cell metabolism and immune diseasesR01AI121156 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHANG, CHEONG-HEE · 2016 to 2020
$1.9M
Targeting T lymphocyte Keap1 for acute kidney injuryR01DK111209 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI RABB, HAMID · 2016 to 2019
$1.8M
NIAID NIH HHS R01 AI121156NIDDK NIH HHS R01 DK111209
6 · The paper itself

Abstract

Kelch-like ECH-associated protein 1 (Keap1) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) proteins work in concert to regulate the levels of reactive oxygen species (ROS). The Keap1-Nrf2 antioxidant system also participates in T cell differentiation and inflammation, but its role in innate T cell development and functions remains unclear. We report that T cell-specific deletion of Keap1 results in defective development and reduced numbers of invariant natural killer T (NKT) cells in the thymus and the peripheral organs in a cell-intrinsic manner. The frequency of NKT2 and NKT17 cells increases while NKT1 decreases in these mice. Keap1-deficient NKT cells show increased rates of proliferation and apoptosis, as well as increased glucose uptake and mitochondrial function, but reduced ROS, CD122, and Bcl2 expression. In NKT cells deficient in Nrf2 and Keap1, all these phenotypic and metabolic defects are corrected. Thus, the Keap1-Nrf2 system contributes to NKT cell development and homeostasis by regulating cell metabolism.

Indexed as

AnimalsCell DifferentiationCell ProliferationCell SurvivalGlucoseGlucose Transporter Type 1Interleukin-2 Receptor beta SubunitKelch-Like ECH-Associated Protein 1MiceMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsNF-E2-Related Factor 2Proto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesThymus GlandGlucoseGlucose Transporter Type 1Interleukin-2 Receptor beta SubunitKeap1 protein, mouseKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Proto-Oncogene Proteins c-bcl-2Reactive Oxygen Speciesantioxidant systemcell metabolisminnate T cellsNKT cellsreactive oxygen species

Identifiers

PMID30995469
PMCPMC6743333
OpenAlexW2936344227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.